High-frequency variant p.T60M in naCl cotransporter and blood pressure variability in Han Chinese

American Journal of Nephrology

Volumn 35, Issue 6, 2012, Pages 515-519

  Shao, Leping ^a   Lang, Yanhua ^a   Wang, Yan ^a   Gao, Yanxia ^a   Zhang, Wei ^a   Niu, Haitao ^a   Liu, Shiguo ^a   Chen, Nan ^b  

^a QINGDAO UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Blood pressure; Chinese; Mutation; NaCl cotransporter; p.Thr60Met

Indexed keywords

GLUCOSE; SODIUM CHLORIDE COTRANSPORTER;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FASTING; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; SODIUM; SODIUM CHLORIDE SYMPORTERS;

EID: 84861329080     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339165     Document Type: Article

References (25)

1. Simon DB, Nelson-Williams C, Bia MJ, et al: Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive NaCl cotransporter. Nat Genet 1996; 12: 24-30.
2. Gitelman HJ, Graham JB, Welt LG: A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Phys 1966; 79: 221-235.
3. Bettinelli A, Bianchetti MG, Girardin E, et al: Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992; 120: 38-43.
4. Shao L, Ren H, Wang W, et al: Novel SLC12A3 mutations in Chinese patients with Gitelman's syndrome. Nephron Physiol 2008; 108: 29-36.
5. Shao L, Liu L, Miao Z, et al: A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney. Am J Nephrol 2008; 28: 900-907.
6. Qin L, Shao L, Ren H, et al: Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome. Nephrology (Carlton) 2009; 14: 52-58.
7. Miao Z, Gao Y, Bindels RJ, et al: Coexistence of normotensive primary aldosteronism in two patients with Gitelman's syndrome and novel thiazide-sensitive NaCl cotransporter mutations. Eur J Endocrinol 2009; 161: 275-283.
8. Dong H, Lang Y, Shao Z, et al: Coexistence of Gitelman's syndrome and thyroid disease: SLCl2A3 gene analysis in two patients. Chin J Endocrinol Metab 2010; 25: 395-398.
9. Anselmo AN, Earnest S, Chen W, et al: WNK1 and OSR1 regulate the Na + ,K + ,2Cl- cotransporter in HeLa cells. Proc Natl Acad Sci USA 2006; 103: 10883-10888.
10. Moriguchi T, Urushiyama S, Hisamoto N, et al: WNK1 regulates phosphorylation of cation- chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 2005; 280: 42685-42693.
11. Rafiqi FH, Zuber AM, Glover M, et al: Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med 2010; 2: 63-75.
12. Richardson C, Sakamoto K, de los Heros P, et al: Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci 2011; 124: 789-800.
13. Richardson C, Alessi DR: The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. J Cell Sci 2008; 121: 3293-3304.
14. Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
15. Genuth S, Alberti KG, Bennett P, et al: The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: followup report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
16. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
17. Ji W, Foo JN, O'Roak BJ, et al: Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40: 592-599.
18. Fava C, Montagnana M, Rosberg L, et al: Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet 2008; 17: 413-418.
19. Hsu YJ, Yang SS, Chu NF, et al: Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure. Nephrol Dial Transplant 2009; 24: 1170-1175.
20. Aoi N, Nakayama T, Sato N, et al: Case-control study of the role of the Gitelman's syndrome gene in essential hypertension. Endocr J 2008; 55: 305-310.
21. Franklin SS, Khan SA, Wong ND, et al: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-360.
22. Shin JY, Lee HR, Lee DC: Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with prediabetes. Cardiovasc Diabetol 2011; 10: 30.
23. Wilson FH, Disse-Nicodeme S, Choate KA, et al: Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112.
24. Wilson FH, Kahle KT, Sabath E, et al: Molecular pathogenesis of inherited hypertension with hyperkalemia: the NaCl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003; 100: 680-684.
25. Lin SH, Cheng NL, Hsu YJ, et al: Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/ chloride cotransporter. Am J Kidney Dis 2004; 43: 304-312.